KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 65 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $113,436 | -47.0% | 14,432 | +61.8% | 0.00% | -100.0% |
| Q2 2021 | $214,000 | -64.9% | 8,919 | -62.4% | 0.00% | -75.0% |
| Q1 2021 | $610,000 | +238.9% | 23,741 | +59.8% | 0.00% | +33.3% |
| Q2 2020 | $180,000 | -69.0% | 14,853 | -80.4% | 0.00% | -80.0% |
| Q1 2020 | $581,000 | -73.5% | 75,910 | -38.3% | 0.02% | +15.4% |
| Q4 2019 | $2,191,000 | +52.5% | 123,043 | -0.7% | 0.01% | 0.0% |
| Q3 2019 | $1,437,000 | -8.9% | 123,887 | +73.9% | 0.01% | -13.3% |
| Q2 2019 | $1,578,000 | – | 71,244 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
| COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
| Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
| Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
| Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
| Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
| APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
| Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |